Kalpna Gupta, PhD
Professor of Medicine, Department of Medicine, Division of Hematology/Oncology
Dr Kalpna Gupta has led pioneering work in understanding the mechanisms of adverse effects of opioids on cancer pain leading to cancer progression, and laid down the foundation of understanding the mechanisms of pain in sickle cell disease (SCD). These insights will help us treat both pain and the underlying disease process causing pain in the first place. Her laboratory has identified several new targets at the intersection of the sickle disease process and pain, including cannabinoid receptors, mast cells, and the nociceptin receptor, in addition to integrative approaches including environment’s modification, acupuncture and perception modulation to relieve pain. Dr Gupta is also a recipient of the Excellence in Hemoglobinopathies Research Award from NHLBI to examine the potential of cannabinoids to treat pain and develop methods to quantify pain objectively. She has served as an advisor to the SCD program at NHLBI/NIH and received the “Pioneer Award” from the Sickle Cell Disease Association od America.